High-throughput RNA FISH analysis by imaging flow cytometry reveals that pioneer factor Foxa1 reduces transcriptional stochasticity

PLoS One. 2013 Sep 20;8(9):e76043. doi: 10.1371/journal.pone.0076043. eCollection 2013.

Abstract

Genes are regulated at the single-cell level. Here, we performed RNA FISH of thousands of cells by flow cytometry (flow-RNA FISH) to gain insight into transcriptional variability between individual cells. These experiments utilized the murine adenocarcinoma 3134 cell line with 200 copies of the MMTV-Ras reporter integrated at a single genomic locus. The MMTV array contains approximately 800-1200 binding sites for the glucocorticoid receptor (GR) and 600 binding sites for the pioneer factor Foxa1. Hormone activation of endogenous GR by dexamethasone treatment resulted in highly variable changes in the RNA FISH intensity (25-300 pixel intensity units) and size (1.25-15 µm), indicative of probabilistic or stochastic mechanisms governing GR and cofactor activation of the MMTV promoter. Exogenous expression of the pioneer factor Foxa1 increased the FISH signal intensity and size as expected for a chromatin remodeler that enhances transcriptional competence through increased chromatin accessibility. In addition, specific analysis of Foxa1-enriched cell sub-populations showed that low and high Foxa1 levels substantially lowered the cell-to-cell variability in the FISH intensity as determined by a noise calculation termed the % coefficient of variation. These results suggest that an additional function of the pioneer factor Foxa1 may be to decrease transcriptional noise.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / genetics*
  • Adenocarcinoma / metabolism
  • Animals
  • Antineoplastic Agents, Hormonal / pharmacology
  • Chromatin Assembly and Disassembly / drug effects
  • DNA Probes
  • Dexamethasone / pharmacology
  • Flow Cytometry*
  • Hepatocyte Nuclear Factor 3-alpha / genetics*
  • Image Processing, Computer-Assisted
  • In Situ Hybridization, Fluorescence*
  • Mammary Tumor Virus, Mouse / genetics*
  • Mice
  • Promoter Regions, Genetic / genetics
  • RNA / genetics*
  • RNA, Messenger / genetics
  • Real-Time Polymerase Chain Reaction
  • Receptors, Glucocorticoid / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transcriptional Activation*
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents, Hormonal
  • DNA Probes
  • Foxa1 protein, mouse
  • Hepatocyte Nuclear Factor 3-alpha
  • RNA, Messenger
  • Receptors, Glucocorticoid
  • RNA
  • Dexamethasone

Grants and funding

This work was supported by the United States Food and Drug Administration (FDA) within the Center for Drug Evaluation and Research (CDER). This project was supported in part by an appointment to the Research Participation Program at CDER administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the United States Department of Energy and FDA [to A.S.L.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.